Literature DB >> 20549037

[Factors related to glaucoma treatment compliance: patients' opinions from a University Hospital].

Lucas Ravagnani Silva1, Jayter Silva de Paula, Eduardo Melani Rocha, Maria de Lourdes Veronese Rodrigues.   

Abstract

PURPOSE: Considering that noncompliance to glaucoma treatment is one of the risk factors associated with disease s progression, the purpose of the present study was to evaluate: 1) knowledge and feelings about the disease; 2) self-reported noncompliance to treatment and related factors; and 3) influence of disease in lifestyle.
METHODS: Interviews, with application of a semi-structured questionnaire, of 50 patients with primary open-angle glaucoma. The analysis was performed using Lefèvre's technique (Collective Subject Speech--CSS, qualitative/quantitative research).
RESULTS: Thirty-eight percent of patients did not consider themselves well informed about glaucoma. The percentage of patients that reported noncompliance was 20%. The main causes of noncompliance are: side effects of antiglaucomatous drugs (24%); lack of information about the disease (22%); difficulty in understanding information and communication problems with the physician (14%); difficulties in administering the eye drops (14%); poverty, with impossibility to pay for the eye drops (10%); patients attitudes and beliefs (10%). Eighteen percent of the participants informed that the disease affected their life quality.
CONCLUSION: In the studied population, most of the problems related to noncompliance to glaucoma treatment pointed out different factors that may decrease with education about POAG, interventions on attitudes and behavior, improvement of doctor-patient relationship and anti-glaucoma drugs supply.

Entities:  

Mesh:

Year:  2010        PMID: 20549037

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  3 in total

1.  Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice.

Authors:  Ines Lanzl; Thomas Raber
Journal:  Clin Ophthalmol       Date:  2011-03-02

2.  Adherence to topical glaucoma medications in Ethiopian patients.

Authors:  Lemlem Tamrat; Girum W Gessesse; Yeshigeta Gelaw
Journal:  Middle East Afr J Ophthalmol       Date:  2015 Jan-Mar

3.  Real-world data from selective laser trabeculoplasty in Brazil.

Authors:  Ricardo Y Abe; Heloísa A Maestrini; Guilherme B Guedes; Marcelo M Nascimento; Camila I Iguma; Hérika Danielle de Miranda Santos; Muna Georges Nasr; Ricarte P Lucena-Junior; Tiago S Prata
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.